Skip to content
10-K

Annual Report

ProPhase Labs, Inc. PRPH

0000868278-26-000005

← back to feed
Filed
Jun 1, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · May 29, 2026 14.02M sh
Shares Diluted FY 2025 · Dec 31, 2025 8.49M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 2M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$8.34M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$17.54M
Cash And Equivalents FY 2025 · Dec 31, 2025 $90K
Cash And Equivalents FY 2025 · Dec 31, 2024 $678K
Stockholders Equity FY 2025 · Dec 31, 2025 $3.51M
Stockholders Equity FY 2025 · Dec 31, 2024 $7.35M
Stockholders Equity FY 2025 · Dec 31, 2023 $49.38M
Current Liabilities FY 2025 · Dec 31, 2025 $53.08M
Current Liabilities FY 2025 · Dec 31, 2024 $32.13M
Total Liabilities FY 2025 · Dec 31, 2025 $56.36M
Total Liabilities FY 2025 · Dec 31, 2024 $55.85M
Current Assets FY 2025 · Dec 31, 2025 $3.15M
Current Assets FY 2025 · Dec 31, 2024 $30.64M
Total Assets FY 2025 · Dec 31, 2025 $59.87M
Total Assets FY 2025 · Dec 31, 2024 $63.2M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.74
Eps Diluted restated FY 2025 · Dec 31, 2024 −$26.68
Eps Basic FY 2025 · Dec 31, 2025 −$1.74
Eps Basic restated FY 2025 · Dec 31, 2024 −$26.68
Sga Expense FY 2025 · Dec 31, 2025 $19.32M
Sga Expense FY 2025 · Dec 31, 2024 $37.89M
Rd Expense FY 2025 · Dec 31, 2025 $107K
Rd Expense FY 2025 · Dec 31, 2024 $594K
Net Income FY 2025 · Dec 31, 2025 −$14.74M
Net Income FY 2025 · Dec 31, 2024 −$53.36M
Operating Income FY 2025 · Dec 31, 2025 −$18.05M
Operating Income FY 2025 · Dec 31, 2024 −$38.63M
Gross Profit FY 2025 · Dec 31, 2025 $1.38M
Gross Profit FY 2025 · Dec 31, 2024 −$150K
Cost Of Revenue FY 2025 · Dec 31, 2025 $2.96M
Cost Of Revenue FY 2025 · Dec 31, 2024 $6.92M
Revenue FY 2025 · Dec 31, 2025 $4.35M
Revenue FY 2025 · Dec 31, 2024 $6.77M